Sean H Lim

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Respiratory Syndrome Coronavirus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Papillary Thyroid

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ratna Wijaya, Sean H Lim
Two approaches to tackling COVID-19 in patients with blood cancer. Nature cancer 4 (1) (2023)
Ratna Wijaya, Sean H Lim
Two approaches to tackling COVID-19 in patients with blood cancer. Nature cancer 4 (1) (2023)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani, Mark S Cragg
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Franziska Heckel, Anna H Turaj, Hayden Fisher, H T Claude Chan, Michael J E Marshall, Osman Dadas, Christine A Penfold, Tatyana Inzhelevskaya, C Ian Mockridge, Diego Alvarado, Ivo Tews, Tibor Keler, Stephen A Beers, Mark S Cragg, Sean H Lim
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. Communications biology 5 (1) (2022)
Sean H Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, Danielle Jeffrey, Anna H Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R Coleman, Benjamin Ward, Karen Long, Helen Coleman, Carina Mundy, Andrew T Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O'Callaghan, Graham P Collins, Tobias Menne, Saul N Faust, Christopher P Fox, Matthew Ahearne, Peter W M Johnson, Andrew J Davies, David Goldblatt
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study. Nature cancer 3 (5) (2022)
Sean H Lim, Peter W M Johnson
Optimizing therapy in advanced-stage Hodgkin lymphoma. Blood 131 (15) (2018)
Anna H Turaj, Kerry L Cox, Christine A Penfold, Ruth R French, C Ian Mockridge, Jane E Willoughby, Alison L Tutt, Jordana Griffiths, Peter W M Johnson, Martin J Glennie, Ronald Levy, Mark S Cragg, Sean H Lim
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking. Scientific reports 8 (1) (2018)